Scientists ejected from diabetes conference for distributing journal reprints

BerislavLopac1 pts0 comments

Scientists ejected from diabetes conference for distributing journal reprints - Ars Technica

Skip to content

AI

Biz & IT

Cars

Culture

Gaming

Health

Policy

Science

Security

Space

Tech

Forum

Subscribe

Story text

Size

Small<br>Standard<br>Large

Width

Standard<br>Wide

Links

Standard<br>Orange

* Subscribers only

Learn more

Pin to story

Theme

Search

Sign In

Sign in dialog...

Text<br>settings

Story text

Size

Small<br>Standard<br>Large

Width

Standard<br>Wide

Links

Standard<br>Orange

* Subscribers only

Learn more

Minimize to nav

Five leading scientists were ousted from the annual meeting of the American Diabetes Association (ADA) in New Orleans on Friday. Their crime: handing out copies of an editorial, published in the journal Diabetes Care on April 29, sharply criticizing the Trump administration’s ongoing attacks on scientific research.

Those ousted were Steven Kahn, professor of medicine at the University of Washington and editor-in-chief of Diabetes Care, who co-authored the published editorial; former ADA president Desmond Schatz of the University of Florida, Gainesville; Aaron Kelly, pediatrics processor at the University of Minnesota; Justin Ryder of Northwestern University; and Irl Hirsch, also of the University of Washington. The five were handing out reprints of the editorial outside a room where NIH director Jay Bhattacharya had been scheduled to speak. Bhattacharya cancelled and another NIH official spoke in his stead.

“They physically grabbed us, forced us out of the conference center, and now are telling us we can no longer attend this meeting,” Kelly told MedPage Today, which first reported the incident. “They’re taking our lanyards. It really has come to this in America. Censorship is real. America needs to stand up. Scientists, stand up. Physicians, stand up.”

The ADA confirmed to MedPage Today that five registered scientists had been removed from the meeting, claiming the scientists had violated the organization’s code of conduct for conferences. “These attendees were escorted out by our onsite event security because they demonstrated behavior not consistent with this code of conduct,” the ADA media team said in a statement. “They were respectfully given the opportunity to cease this behavior and chose not to which is why they were escorted out.”

“All attendees will conduct themselves in a professional and respectful manner, free from any form of discrimination, harassment, or intimidation,” the code of conduct states. “Inappropriate conduct, including but not limited to harassment; threatening or unwelcome physical or verbal actions; or disorderly or disruptive conduct such as protesting, will not be tolerated.”

Online backlash to the ADA’s actions spread rapidly on both Twitter/X and BlueSky, and sharply increased the number of page views for Kahn et al.’s April editorial. According to Kahn, the editorial was published with a disclaimer, added by ADA leadership, insisting that the ADA had nothing to do with developing or writing the article. He has written to the ADA seeking re-admittance to the conference, since he is slated to speak and chair a session.

Some questioned how handing out reprints of an editorial published in the ADA’s own journal, at the ADA’s own annual conference, could be construed as a violation of that code. The scientists were not disruptive or disorderly in their conduct, based on the videos posted by MedPage Today, although the fact that they were handing out reprints just before an NIH representative was scheduled to speak might be construed as a form of protest. But it could just as easily be argued that such actions fall under valid scientific dissemination and discussion, the conference’s stated objective.

“It is no longer enough to stand idly by or work behind the scenes with lawmakers,” the authors wrote in their editorial. “Moreover, it is no longer appropriate to fret about political backlash. Now is the time to recognize and fight to reverse the spiraling fall of the United States of America’s status as the foremost nation in health care innovation. As a nation, we must continue to believe in ensuring better health for all. A few brushes of a pen, some clearly visible through budget requests, others less so through internal machinations, are rapidly destroying what generations have built. We can no longer afford complacency and fear. We must all act now!”

DOI: Diabetes Care, 2026. 10.2337/dci26-0068  (About DOIs).

Jennifer Ouellette

Senior Writer

Jennifer Ouellette

Senior Writer

Jennifer is a senior writer at Ars Technica with a particular focus on where science meets culture, covering everything from physics and related interdisciplinary topics to her favorite films and TV series. Jennifer lives in Baltimore with her spouse, physicist Sean M. Carroll, and their two cats, Ariel and Caliban.

107 Comments

Comments

Forum view

Loading comments...

Prev story

1.<br>S&P 500 rejects SpaceX, also blocking entry for OpenAI and...

scientists editorial conduct from diabetes conference

Related Articles